[Clinical Value of Detecting MYD88 L265P Mutation in the Plasma of Patients with Treatment-Naive Diffuse Large B-Cell Lymphoma via Droplet Digital PCR]
{{output}}
Objective: To detect the MYD88 L265P mutation in cell-free DNA (cfDNA) from the plasma of patients with treatment-naive diffuse large B-cell lymphoma (DLBCL) using droplet digital PCR (ddPCR) technology, and to explore its associ... ...
